Literature DB >> 11733686

Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury.

R B Banati1, A Cagnin, D J Brooks, R N Gunn, R Myers, T Jones, R Birch, P Anand.   

Abstract

Limb denervation leads to reorganization of the representational zones of the somatosensory cortex. Using [11C](R)-PK11195, a sensitive in vivo marker of glial cell activation, and PET, we provide first evidence that limb denervation induces a trans-synaptic increase in [11C](R)-PK11195 binding in the human thalamus but not somatosensory cortex: these brain structures appeared morphologically normal on magnetic resonance imaging (MRI). The increased thalamic signal was detectable many years after nerve injury, indicating persistent reorganization of the thalamus. This glial activation, beyond the first-order projection area of the injured neurons, may reflect continually altered afferent activity. Our findings support the view that long-term rearrangement of cortical representational maps is significantly determined within the thalamus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733686     DOI: 10.1097/00001756-200111160-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  42 in total

1.  Imaging of neuroinflammation.

Authors:  Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12       Impact factor: 9.236

Review 2.  Positron emission tomography imaging of neuroinflammation.

Authors:  Annachiara Cagnin; Michael Kassiou; Steve R Meikle; Richard B Banati
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 3.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.

Authors:  Linda R Watkins; Mark R Hutchinson; Kenner C Rice; Steven F Maier
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

4.  Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Per Karlsson; Nils Sjoholm; Stig Larsson; Cathrine Jonsson; Richard Odh; Richard Sparks; Nabil Al Tawil; Anja Hoffmann; Torsten Zimmermann; Andrea Thiele; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

Review 5.  The young brain and concussion: imaging as a biomarker for diagnosis and prognosis.

Authors:  Esteban Toledo; Alyssa Lebel; Lino Becerra; Anna Minster; Clas Linnman; Nasim Maleki; David W Dodick; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2012-03-28       Impact factor: 8.989

6.  IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain.

Authors:  Niels Eijkelkamp; Cristine Steen-Louws; Sarita A Y Hartgring; Hanneke L D M Willemen; Judith Prado; Floris P J G Lafeber; Cobi J Heijnen; C E Hack; Joel A G van Roon; Annemieke Kavelaars
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

Review 7.  Activity-triggered tetrapartite neuron-glial interactions following peripheral injury.

Authors:  Ke Ren; Ronald Dubner
Journal:  Curr Opin Pharmacol       Date:  2015-09-30       Impact factor: 5.547

Review 8.  Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential.

Authors:  Kazuhide Inoue; Makoto Tsuda
Journal:  Nat Rev Neurosci       Date:  2018-02-08       Impact factor: 34.870

Review 9.  Pathological pain and the neuroimmune interface.

Authors:  Peter M Grace; Mark R Hutchinson; Steven F Maier; Linda R Watkins
Journal:  Nat Rev Immunol       Date:  2014-02-28       Impact factor: 53.106

Review 10.  Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.

Authors:  Long-Jun Wu; Min Zhuo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.